As we know, that world is suffering from a global COVID-19 outbreak, and scientists are trying hard to find an effective drug against coronavirus. Australian researcher teams of Monash University in Melbourne have found that FDA approved anti-parasitic drug named Ivemectin gives positive results from growing in cell culture and was effective against viruses of Flu, Zika, HIV and SARS- CoV-2.
While promising, the medicine still can’t seem to be appeared to have a similar impact inside the human body, in light of the fact that the Australian research was done “in vitro analysis,” which means it was in a Petri dish at a lab. The scientists are trying hard funding of pre-clinical and clinical trials, after which they have to begin the process of approval of experiments themselves.
The researchers are confident about results; they said just in 48 hours, all types of the genetic material of the virus were wiped out.
According to Kylie Wagstaff (Co-author)
He said in a statement that, “we found that even a single dose was effective to eradicate all RNA in 48 hours and in a day significant reduction was seen in it.”
Ivermectin is effective against viruses. So we have to figure out whether the dose is effective for humans or not, which is the next step.
Wagstaff said in the statement, “credibly it’s going to be a while before a vaccine is generally available.”
According to Leon Caly Research
A senior medical scientist at the Doherty Institute working in the lab of Victorian Infectious Disease Research (VIDRL) said, as a virologist, I am excited about the prospect of Ivermectin being used as an effective medicine against the COVID-19.
A vaccine for COVID-19 is likely still at least a year out, despite research groups over the world optimizing chip away at potential immunizations. Be that as it might, that doesn’t mean we’re damned.
At the time when we are having a global outbreak of COVID-19 without an approved treatment, if we had a drug that is available already in the world might help the world to save against coronavirus sooner.